The opioid problem in the US is on an epidemic level. In 2019 the use of synthetic opioids such as fentanyl caused an increasing number of deaths, while the overall number of overdose deaths declined slightly. There is still a huge need for treatment and in 2019 the dynamic buprenorphine/naloxone market grew by over 14 percent.1

1 IQVIA Data